ArticleThe Biochemical journal2016

Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy.

Itay Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.